Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA)

1.

Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, et al. Anti-human leukocyte antigen

and donor-specific antibodies detected by lumine posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87(10): 1505–1513. https://doi.org/10.1097/TP.

0b013e3181a44206 PMID: 19461487

2.

O’Leary JG, Kaneku H, Susskind BM, Jennings LW, Neri MA, Davis GL, et al. High mean fluorescence

intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J

Transplant. 2011; 11(9): 1868–1876. https://doi.org/10.1111/j.1600-6143.2011.03593.x PMID: 21672151

3.

Kaneku H, O’Leary JG, Taniguchi M, Susskind BM, Terasaki PI, Klinmalm GB. Donor-specific human

leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection

and graft loss after liver transplantation. Liver Transpl. 2012; 18(8): 984–992. https://doi.org/10.1002/lt.

23451 PMID: 22508525

4.

Otten HG, Verhaar MC, Borst HP, van Eck M, van Ginkel WG, Hene RJ, et al. The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney

transplantation. Clin Exp Immunol. 2013; 173(3): 536–543. https://doi.org/10.1111/cei.12127 PMID:

23627692

PLOS ONE | https://doi.org/10.1371/journal.pone.0236614 February 5, 2021

19 / 20

PLOS ONE

Humanized mouse model to analyze antibodies specific for HLA

5.

Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005; 5(10): 807–

817. https://doi.org/10.1038/nri1702 PMID: 16175181

6.

Sicard A, Phares TW, Yu H, Fan R, Baldwin WM 3rd, Fairchild RL, et al. The spleen is the major source

of antidonor antibody-secreting cells in murine heart allograft recipients. Am J Transplant. 2012; 12(7):

1708–1719. https://doi.org/10.1111/j.1600-6143.2012.04009.x PMID: 22420367

7.

Villaudy J, Schotte R, Legrand N, Spits H. Critical assessment of human antibody generation in humanized mouse models. J Immunol Methods 2014; 410: 18–27. https://doi.org/10.1016/j.jim.2014.06.010

PMID: 24952244

8.

Hogenes M, Huibers M, Kroone C, de Weger R. Humanized mouse models in transplantation research.

Transplant Rev (Orlando). 2014; 28(3): 103–110. https://doi.org/10.1016/j.trre.2014.02.002 PMID:

24636846

9.

Nakauchi Y, Yamazaki S, Napier SC, Usui J, Ota Y, Takahashi S, et al. Effective treatment against

severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized

mouse model. Exp Hematol. 2015; 43(2): 79–88. https://doi.org/10.1016/j.exphem.2014.10.008 PMID:

25448490

10.

Kenney LL, Shultz LD, Greiner DL, Brehm MA. Humanized mouse models for transplant immunology.

Am J Transplant. 2016; 16(2): 389–397. https://doi.org/10.1111/ajt.13520 PMID: 26588186

11.

Theocharides AP, Rongvaux A, Fritsch K, Flavell RA, Manz MG. Humanized hemato-lymphoid system

mice. Haematologica. 2016; 101(1): 5–19. https://doi.org/10.3324/haematol.2014.115212 PMID:

26721800

12.

Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC. CD40 ligand triggered interleukin-6

secretion in multiple myeloma. Blood. 1995; 85(7):1903–12. PMID: 7535594

13.

Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone

Marrow Transplant. 2013; 48(3): 452–458. https://doi.org/10.1038/bmt.2012.244 PMID: 23208313

14.

Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice

with severe combined immunodeficiency. Nature. 1988; 335:256–259. https://doi.org/10.1038/

335256a0 PMID: 2970594

15.

Andrade D, Redecha PB, Vukelic M, Qing X, Perino G, Salom JE, et al. Engraftment of peripheral blood

mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors

into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease. Arthritis Rheum.

2011; 63(9):2764–2773. https://doi.org/10.1002/art.30424 PMID: 21560114

16.

Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishi N, Katano I, et al. The analysis of the functions

of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int

Immunol. 2009; 21(7): 843–858. https://doi.org/10.1093/intimm/dxp050 PMID: 19515798

17.

Harman BC, Giles-Komar J, Rycyzyn MA. Antibody discovery from immune competent and immune

transplanted mice. Curr Drug Discov Technol. 2014; 11(1): 65–73. https://doi.org/10.2174/

15701638113109990036 PMID: 23978038

18.

Zhang T, Pierson RN 3rd, Azimzadeh AM. Update on CD40 and CD154 blockade in transplant models.

Immunotherapy 2015; 7(8): 899–911. https://doi.org/10.2217/IMT.15.54 PMID: 26268734

19.

Ahmadi T, Files A, Efebera Y, Sherr DH. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendric cells in presenting protein antigens and major histocompatibility complex classⅠand class Ⅱ-binding peptides. Immunology. 2008; 124(1): 129–140. https://doi.org/10.1111/j.13652567.2007.02749.x PMID: 18067555

20.

Lang J, Kelly M, Freed BM, McCarter MD, Kedl RM, Torres RM, et al. Studies of lymphocyte reconstitution in a humanized mouse reveal a requirement of T cells for human B cell maturation. J Immunol

2013; 190(5):2090–2210. https://doi.org/10.4049/jimmunol.1202810 PMID: 23335750

21.

Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015; 15(3): 185–189. https://doi.org/

10.1038/nri3803 PMID: 25677493

22.

Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002; 2(7):

465–475. https://doi.org/10.1038/nri844 PMID: 12094221

23.

Nojima T, Haniuda K, Moutai T, Matsudaira M, Mizokawa S, Shiratori I, et al. In-vitro derived germinal

centre B cells differentially generate memory B or plasma cells in vivo. Nat Commun. 2011; 2: 465.

https://doi.org/10.1038/ncomms1475 PMID: 21897376

PLOS ONE | https://doi.org/10.1371/journal.pone.0236614 February 5, 2021

20 / 20

...